References
Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP (2000) Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical inhaled nitric oxide research group. N Engl J Med 342: 469–474
Janney CG, Askin FB, Kuhn C (1981) Congenital alveolar capillary dysplasia – an unusual cause of respiratory distress in the newborn. Am J Clin Pathol 76: 722–727
Newman B, Yunis E (1990) Primary alveolar capillary dysplasia. Pediatr Radiol 21: 20–22
Steinhorn RH, Cox PN, Fineman JR, Finer NN, Rosenberg EM, Silver MM, Tyebkhan J, Zwass MS, Morin FC (1997) Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr 130: 417–422
Vassal HB, Malone M, Petros AJ, Winter RM (1998) Familial persistent pulmonary hypertension of the newborn resulting from misalignment of the pulmonary vessels (congenital alveolar capillary dysplasia). J Med Genet 35: 58–60
Wagenvoort CA (1986) Misalignment of lung vessels: a syndrome causing persistent neonatal pulmonary hypertension. Human Pathol 17: 727–730
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Licht, C., Schickendantz, S., Sreeram, N. et al. Prolonged survival in alveolar capillary dysplasia syndrome. Eur J Pediatr 163, 181–182 (2004). https://doi.org/10.1007/s00431-003-1385-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-003-1385-6